In-Depth Understanding of the Impact of Material Properties on the Performance of Jet Milling of Active Pharmaceutical Ingredients.

IF 5.5 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Viktor Bultereys, Kensaku Matsunami, Laure Descamps, Roel Mertens, Alain Collas, Ashish Kumar
{"title":"In-Depth Understanding of the Impact of Material Properties on the Performance of Jet Milling of Active Pharmaceutical Ingredients.","authors":"Viktor Bultereys, Kensaku Matsunami, Laure Descamps, Roel Mertens, Alain Collas, Ashish Kumar","doi":"10.3390/pharmaceutics17091197","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives:</b> Among different milling techniques, spiral air jet milling can produce finer particles without the use of solvents or additives, thereby improving the bioavailability and content uniformity of the final dosage form. However, milling can complicate downstream processability of active pharmaceutical ingredients (APIs) due to reduced bulk powder flowability and post-milling lump formation. Process settings are often optimized only for particle size reduction, without sufficient consideration of manufacturability, largely because of limited API availability and a lack of knowledge about influential material properties. This study aimed to investigate the impact of material properties and process settings on milling performance and downstream manufacturability. <b>Methods:</b> Four APIs, examined in a total of eight grades, were characterized for their bulk mechanical properties and compression energy parameters using a compaction simulator. These grades were subjected to milling experiments within a design-of-experiments framework. Statistical analyses were performed, and population balance models (PBMs) were developed and calibrated for each experiment to link material properties and process settings to milling outcomes. <b>Results:</b> A higher gas flow rate was identified as the most significant contributor to particle size reduction. The influence of mechanical properties, particularly Young's modulus and Poisson's ratio, was evident and correlated with unmilled particle sizes. PBM analyses showed that a higher gas feed rate decreased the critical particle size for breakage, while intrinsic mechanical properties affected the breakage rate function. <b>Conclusions:</b> By integrating material properties and process settings into PBM analyses, specific breakage mechanisms could be identified. These findings provide a framework for optimizing jet milling not only for particle size reduction but also for downstream processability of APIs.</p>","PeriodicalId":19894,"journal":{"name":"Pharmaceutics","volume":"17 9","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12473772/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/pharmaceutics17091197","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: Among different milling techniques, spiral air jet milling can produce finer particles without the use of solvents or additives, thereby improving the bioavailability and content uniformity of the final dosage form. However, milling can complicate downstream processability of active pharmaceutical ingredients (APIs) due to reduced bulk powder flowability and post-milling lump formation. Process settings are often optimized only for particle size reduction, without sufficient consideration of manufacturability, largely because of limited API availability and a lack of knowledge about influential material properties. This study aimed to investigate the impact of material properties and process settings on milling performance and downstream manufacturability. Methods: Four APIs, examined in a total of eight grades, were characterized for their bulk mechanical properties and compression energy parameters using a compaction simulator. These grades were subjected to milling experiments within a design-of-experiments framework. Statistical analyses were performed, and population balance models (PBMs) were developed and calibrated for each experiment to link material properties and process settings to milling outcomes. Results: A higher gas flow rate was identified as the most significant contributor to particle size reduction. The influence of mechanical properties, particularly Young's modulus and Poisson's ratio, was evident and correlated with unmilled particle sizes. PBM analyses showed that a higher gas feed rate decreased the critical particle size for breakage, while intrinsic mechanical properties affected the breakage rate function. Conclusions: By integrating material properties and process settings into PBM analyses, specific breakage mechanisms could be identified. These findings provide a framework for optimizing jet milling not only for particle size reduction but also for downstream processability of APIs.

深入了解物料性质对有效药物成分射流研磨性能的影响。
背景/目的:在不同的碾磨技术中,螺旋气流碾磨可以在不使用溶剂或添加剂的情况下产生更细的颗粒,从而提高最终剂型的生物利用度和含量均匀性。然而,碾磨会使活性药物成分(api)的下游加工能力复杂化,因为散装粉末流动性降低,碾磨后形成块状。工艺设置通常只针对减小粒度进行优化,而没有充分考虑可制造性,这主要是因为有限的API可用性和缺乏对有影响的材料特性的了解。本研究旨在探讨材料性能和工艺设置对铣削性能和下游可制造性的影响。方法:四种原料药,共检查了八个等级,表征了他们的整体力学性能和压缩能参数使用压实模拟器。这些等级在实验设计框架内进行了铣削实验。进行了统计分析,并为每个实验开发和校准了人口平衡模型(PBMs),以将材料特性和工艺设置与铣削结果联系起来。结果:较高的气体流速被确定为颗粒尺寸减小的最重要贡献者。力学性能,特别是杨氏模量和泊松比的影响是明显的,并且与未磨粒度相关。PBM分析表明,较高的进气量降低了破碎临界粒径,而固有力学性能影响破碎率函数。结论:通过将材料特性和工艺设置整合到PBM分析中,可以确定具体的破损机制。这些发现为优化射流铣削提供了一个框架,不仅可以降低粒度,还可以提高原料药的下游加工能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutics
Pharmaceutics Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.90
自引率
11.10%
发文量
2379
审稿时长
16.41 days
期刊介绍: Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications,  and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信